Laurus Labs Q2 Results
- BSE: 540222
- NSE: LAURUSLABS
- ISIN: INE947Q01028
- Sector: Biotechnology & Drugs
BSE
556.9
-20.00 (-3.47%)
-20.00 (-3.47%)Volume77.63 K
Updated: Wed 22 Jan, 2025 | 12:59:51
NSE
557.5-19.40 (-3.36%)
-19.40 (-3.36%)Volume7.57 L
Updated: Wed 22 Jan, 2025 | 12:44:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,223.70 Cr.(-0.06%)
- Operating Profit₹70.82 Cr.(-25.06%)
- Profit After Tax₹19.84 Cr.(-46.31%)
- Operating Margin5.79%(-25.01%)
Note: Comparison is on YoY basis
Quarterly - Laurus Labs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,223.70 | 1,194.91 | 2.41% | 1,224.45 | -0.06% |
| Selling/ General/ Admin Expenses Total | 178.72 | 173.98 | 2.72% | 163.93 | 9.02% |
| Depreciation/ Amortization | 107.51 | 106.66 | 0.80% | 93.37 | 15.14% |
| Other Operating Expenses Total | 318.35 | 312.28 | 1.94% | 291.57 | 9.18% |
| Total Operating Expense | 1,152.88 | 1,129.77 | 2.05% | 1,129.95 | 2.03% |
| Operating Income | 70.82 | 65.14 | 8.72% | 94.50 | -25.06% |
| Net Income Before Taxes | 22.81 | 18.46 | 23.56% | 53.89 | -57.67% |
| Net Income | 19.84 | 12.42 | 59.74% | 36.95 | -46.31% |
| Diluted Normalized EPS | 0.37 | 0.23 | 60.87% | 0.68 | -45.59% |